Ovarian malignancy in patients with dermatomyositis and polymyositis: a retrospective analysis of fourteen cases
- PMID: 9366818
- DOI: 10.1016/s0190-9622(97)70109-9
Ovarian malignancy in patients with dermatomyositis and polymyositis: a retrospective analysis of fourteen cases
Abstract
Background: Dermatomyositis and polymyositis can be associated with an underlying malignancy.
Objective: Our purpose was to describe a group of patients with dermatomyositis and polymyositis in whom ovarian carcinoma was diagnosed and to evaluate further the characteristics of the association between these diseases.
Methods: A cross-sectional retrospective review identified 14 patients in a 45-year period (1950 to 1995) with dermatomyositis and polymyositis in whom an underlying ovarian malignancy was diagnosed. Clinical and laboratory data of these patients were reviewed, and immunofluorescent and hematoxylin-eosin-stained skin sections were examined.
Results: The mean age at diagnosis of dermatomyositis and polymyositis was 59 years. Of the 14 patients, 11 had dermatomyositis, two had polymyositis, and one had an overlap disease. The 12 patients with dermatomyositis had distinctive cutaneous lesions. In eight, cutaneous biopsy specimens demonstrated variable histologic changes. Thirteen patients had signs of proximal muscle weakness, and myopathy was further demonstrated by electromyographic testing in 10. Creatine kinase levels were increased in 6 of the 10 patients tested. Dysphagia was present in five patients, but esophageal dysmotility was not demonstrated in three. Dermatomyositis and polymyositis preceded the ovarian malignancy in nine patients, were concomitant with it in four, and succeeded the ovarian disease in one.
Conclusion: Physical examination and imaging techniques failed to detect early ovarian cancer in our patients with dermatomyositis and polymyositis. When detected (usually by abdominopelvic examination, in two by computed tomographic examination), it was advanced, and survival was poor.
Similar articles
-
Gynecologic carcinoma associated with dermatomyositis-polymyositis.Obstet Gynecol. 1984 Nov;64(5):695-8. Obstet Gynecol. 1984. PMID: 6493661
-
Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study.Int J Dermatol. 2002 Nov;41(11):729-34. doi: 10.1046/j.1365-4362.2002.01648.x. Int J Dermatol. 2002. PMID: 12452993
-
Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak General Hospital.Rheumatol Int. 2012 Jan;32(1):265-8. doi: 10.1007/s00296-010-1745-2. Epub 2011 Jan 18. Rheumatol Int. 2012. PMID: 21243497
-
Hematological malignancy associated with polymyositis and dermatomyositis.Autoimmun Rev. 2012 Jul;11(9):615-20. doi: 10.1016/j.autrev.2011.10.024. Epub 2011 Oct 30. Autoimmun Rev. 2012. PMID: 22079677 Review.
-
Dermatomyositis and ovarian cancer: a report of 7 cases and literature review.J Rheumatol. 1993 Nov;20(11):1897-9. J Rheumatol. 1993. PMID: 8308775 Review.
Cited by
-
Dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review.Contemp Oncol (Pozn). 2020;24(4):252-257. doi: 10.5114/wo.2020.102814. Epub 2021 Jan 4. Contemp Oncol (Pozn). 2020. PMID: 33531873 Free PMC article. Review.
-
Rapid development and use of patient-specific ctDNA biomarkers to avoid a "rash decision" in an ovarian cancer patient.Cold Spring Harb Mol Case Stud. 2019 Dec 13;5(6):a004648. doi: 10.1101/mcs.a004648. Print 2019 Dec. Cold Spring Harb Mol Case Stud. 2019. PMID: 31628202 Free PMC article.
-
Clear cell ovarian carcinoma following polymyositis diagnosis: a case report and review of the literature.Hippokratia. 2008 Jul;12(3):181-5. Hippokratia. 2008. PMID: 18923746 Free PMC article.
-
Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery.Gynecol Oncol Case Rep. 2013 Jul 16;6:13-5. doi: 10.1016/j.gynor.2013.07.002. eCollection 2013. Gynecol Oncol Case Rep. 2013. PMID: 24371708 Free PMC article.
-
Paraneoplastic myositis secondary to poorly differentiated serous carcinoma of ovarian/tubal origin.Gynecol Oncol Rep. 2017 Apr 5;20:112-114. doi: 10.1016/j.gore.2017.04.001. eCollection 2017 May. Gynecol Oncol Rep. 2017. PMID: 28435850 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical